FeedbackLSE:FDBK FCF Yield % is -131.05 as of Jun. 29, 2026. The stock has 4 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Feedback ranks worse than 97.07% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
The historical rank and industry rank for Feedback's FCF Yield % or its related term are showing as below:
LSE:FDBK'
s FCF Yield % Range Over the Past 10 Years
Min: -192.69 Med: -29.37 Max: -1.17
Current: -131.05
During the past 13 years, the highest FCF Yield % of Feedback was -1.17%. The lowest was -192.69%. And the median was -29.37%.
LSE:FDBK's FCF Yield % is ranked worse than 97.07% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 1.88
vs LSE:FDBK: -131.05
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Feedback FCF Yield % Related Terms
Feedback FCF Yield % Historical Data
* Premium members only.
The historical data trend for Feedback's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:FDBK vs VEEV, BTSG, TEM: FCF Yield % Comparison
For the Health Information Services subindustry, Feedback's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Feedback FCF Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Feedback's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Feedback's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Feedback (LSE:FDBK) has a FCF Yield % of -131.05 as of Jun. 29, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Feedback and its competitors. According to the industry distribution chart, Feedback ranks #663 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 97.1%.
Is Feedback's FCF Yield % too high?
Feedback's current FCF Yield % is -131.05. Based on the distribution chart, Feedback ranks #663 out of 683 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does Feedback's FCF Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Feedback ranks #663 out of 683 companies for FCF Yield %. This places Feedback in the lower half of its industry. The industry median FCF Yield % is 1.88. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Healthcare Providers & Services company?
The median FCF Yield % among Healthcare Providers & Services companies is 1.88, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Feedback and its competitors. For the Healthcare Providers & Services industry, the median FCF Yield % is 1.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Feedback's current FCF Yield % is -131.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Feedback stock overvalued right now?
Based on GuruFocus' analysis, Feedback (LSE:FDBK) is currently considered Possible Value Trap. The stock's GF Value™ is £0.14, compared to a current price of £0.07 — trading 49.3% below its estimated fair value. The current FCF Yield % is -131.05. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Feedback (LSE:FDBK), the current FCF Yield % is -131.05 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making, and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. Its operating segments include Medical Imaging and Feedback Medical Imaging India. Its products include Bleepa, a regulated communication platform for sharing clinical results and supporting multidisciplinary teamwork, and CareLocker, a patient-facing platform that provides access and control over diagnostic and clinical data.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:FDBK has been successfully added to your 